Gapping down
In reaction to disappointing earnings/guidance: INFN -32.1%, RCII -17.6%,SCKT -12.5%, (thinly traded), WSTL -11.3%, (Westell Tech estimates preliminary consolidated revenue for 1Q17 of $14.8 mln vs Cap IQ Consensus of $21.03 mln; announces plans to to reduce annual expenses by ~$11.0 mln), RRTS -11%, LPSN -11%, KONA -9.8%, TER -7.8%, F -6.7%, INT -5.6%, (also corrects previously reported financials due to accounting of taxes ),SPRT -5.2%, ORC -5.1%, NAP -5.1%, NATI -4.9%, WFM -4.9%, IAC -4.7%,OTEX -4.5%, (also announces new $200,000,000 stock buyback authorization), SNN -4.5%, TEF -4.5%, DLB -4.1%, WLL -4.1%, ELY -4.1%,KNX -3.9%, MMLP -3.8%, PRLB -3.8%, KRA -3.7%, KRA -3.7%, MAR -3.6%,TREE -3.5%, ECHO -3.1%, NAT -3.1%, LYG -3%, RDS.A -2.9%, HOG -2.7%,CBI -2.3%, POT -2%, NE -1.9%, CS -1.8%, GG -1.7%, CA -1.6%, GG -1.5%, IGT-1.5%, VRTX -1.4%, CIT -1.4%, ALSN -1.3%, EURN -1.1%, RPM -1.1%, MCK-1%, KGC -1%, FIG -1%, ORLY -0.9%, TYL -0.9%, HP -0.9%
Other news:
In reaction to disappointing earnings/guidance: INFN -32.1%, RCII -17.6%,SCKT -12.5%, (thinly traded), WSTL -11.3%, (Westell Tech estimates preliminary consolidated revenue for 1Q17 of $14.8 mln vs Cap IQ Consensus of $21.03 mln; announces plans to to reduce annual expenses by ~$11.0 mln), RRTS -11%, LPSN -11%, KONA -9.8%, TER -7.8%, F -6.7%, INT -5.6%, (also corrects previously reported financials due to accounting of taxes ),SPRT -5.2%, ORC -5.1%, NAP -5.1%, NATI -4.9%, WFM -4.9%, IAC -4.7%,OTEX -4.5%, (also announces new $200,000,000 stock buyback authorization), SNN -4.5%, TEF -4.5%, DLB -4.1%, WLL -4.1%, ELY -4.1%,KNX -3.9%, MMLP -3.8%, PRLB -3.8%, KRA -3.7%, KRA -3.7%, MAR -3.6%,TREE -3.5%, ECHO -3.1%, NAT -3.1%, LYG -3%, RDS.A -2.9%, HOG -2.7%,CBI -2.3%, POT -2%, NE -1.9%, CS -1.8%, GG -1.7%, CA -1.6%, GG -1.5%, IGT-1.5%, VRTX -1.4%, CIT -1.4%, ALSN -1.3%, EURN -1.1%, RPM -1.1%, MCK-1%, KGC -1%, FIG -1%, ORLY -0.9%, TYL -0.9%, HP -0.9%
Other news:
- HK -27.5% (confirms filing voluntary petitions under chapter 11 of the Bankruptcy Code to pursue a pre-packaged plan of reorganization)
- ARGS -14.9% (provides corporate update in conjunction with proposed offering of common stock and warrants )
- IVTY -12% (announces proposed public offering of common stock; details not disclosed)
- CIEN -5.9% (INFN sympathy)
- EXAS -5.2% (announces upsizing and pricing of public offering of common stock)
- RGLS -4.1% (Regulus Therapeutics announces that, as anticipated, it received written communication from the FDA outlining information required to resolve the clinical hold for its IND for RG-101)
- AXTA -3.1% (announces sale of 41,621,996 common shares by affiliates of The Carlyle Group (CG) for $28.97/share)
- NAT -2.7% (lowers quarterly dividend to $0.25/share from $0.43/share)
- VALE -1.4% (Vale S.A. informs about provision related to the agreement with Brazilian authorities; BHP Billiton will also make available to Samarco similar short-term facilities)
- AGNC -0.8% (decreases monthly dividend to $0.18/share from $0.20/share)
Analyst comments: X -1.2% (downgraded to Underperform from Neutral at BofA/Merrill)